These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Wells RG; Havens PL Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898 [TBL] [Abstract][Full Text] [Related]
26. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cameron R; Davies HR Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881 [TBL] [Abstract][Full Text] [Related]
27. Intrapleural streptokinase in complicated parapneumonic effusions and empyema. Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826 [TBL] [Abstract][Full Text] [Related]
28. Intrapleural fibrinolysis and DNase versus video-assisted thoracic surgery (VATS) for the treatment of pleural empyema (FIVERVATS): protocol for a randomised, controlled trial - surgery as first-line treatment. Christensen TD; Bendixen M; Skaarup SH; Jensen JU; Petersen RH; Christensen M; Licht P; Neckelmann K; Bibby BM; Møller LB; Bodtger U; Borg MH; Saghir Z; Langfeldt S; Harders SMW; Bedawi EO; Naidu B; Rahman N; Laursen CB BMJ Open; 2022 Mar; 12(3):e054236. PubMed ID: 35264347 [TBL] [Abstract][Full Text] [Related]
29. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia. Muhammad Redzwan SRA Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131 [TBL] [Abstract][Full Text] [Related]
30. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis. Chong WH; Hu K; Saha BK; Chopra A Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897 [TBL] [Abstract][Full Text] [Related]
32. Intrapleural therapy in management of complicated parapneumonic effusions and empyema. Ahmed AH; Yacoub TE Clin Pharmacol; 2010; 2():213-21. PubMed ID: 22291507 [TBL] [Abstract][Full Text] [Related]
33. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project. Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671 [TBL] [Abstract][Full Text] [Related]
34. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Froudarakis ME; Kouliatsis G; Steiropoulos P; Anevlavis S; Pataka A; Popidou M; Mikroulis D; Pneumatikos I; Bouros D Respir Med; 2008 Dec; 102(12):1694-700. PubMed ID: 18824340 [TBL] [Abstract][Full Text] [Related]
35. Intrapleural Thrombolytics for Parapneumonic Effusion: A Network Metaanalysis. Sridharan K; Sivaramakrishnan G Curr Rev Clin Exp Pharmacol; 2024; 19(2):204-212. PubMed ID: 36173062 [TBL] [Abstract][Full Text] [Related]
36. New strategies to manage complicated pleural effusions. Safiyeh M; Huang D Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656 [TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections. McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574 [TBL] [Abstract][Full Text] [Related]
38. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study. Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784 [TBL] [Abstract][Full Text] [Related]
39. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience. Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627 [TBL] [Abstract][Full Text] [Related]
40. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Tokuda Y; Matsushima D; Stein GH; Miyagi S Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]